MedTrace Logo

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

NCT01703585 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2018-05-09

No results posted yet for this study

Summary

This is a feasibility study to look for genetic alterations in tissue and blood samples that may be useful in determining what treatments may be useful in the patient's cancer care.

Conditions

Sponsors & Collaborators

  • Ontario Institute for Cancer Research

    collaborator OTHER

  • Princess Margaret Hospital, Canada

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Lillian Siu, MD · Princess Margaret Cancer Centre

  • Bedard Philippe, MD · Princess Margaret Cancer Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-04
Primary Completion
2018-05-01
Completion
2018-05-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01703585 on ClinicalTrials.gov